Lack of Benefit With Combination Therapy for Clostridium difficile Infection

Publisher： Cambridge University Press

E-ISSN： 1559-6834|38|5|602-605

ISSN： 0899-823x

Source： Infection Control & Hospital Epidemiology, Vol.38, Iss.5, 2017-02, pp. : 602-605

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Appropriateness of empiric therapy in patients with suspected Clostridium difficile infection

By Saade Elie  

Current Medical Research and Opinion, Vol. 29, Iss. 8, 2013-08 ,pp. : 985-988

Informa Healthcare

Access to resources Recommend Favorite

Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 8, 2015-10 ,pp. : 1030-1030

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection – authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 269-2813, Iss. 8, 2015-10 ,pp. : 1031-1031

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 8, 2015-10 ,pp. : 1030-1030

John Wiley & Sons Inc

Access to resources Recommend Favorite

Letter: faecal microbiota transplantation in combination with fidaxomicin to treat severe complicated recurrent Clostridium difficile infection – authors' reply

By  

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol. 42, Iss. 8, 2015-10 ,pp. : 1031-1031

John Wiley & Sons Inc

Access to resources Recommend Favorite